Breast cancer survivors may have lower risk of developing Alzheimer’s disease, study finds

FDA approves first AI tool to predict breast cancer risk

The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk.The authorization was confirmed by digital health tech company Clairity, the developer of Clairity Breast – a novel, image-based...